Immunohistochemical expression of uPA, PAl-1, cathepsin D and apoptotic cells in ductal carcinomain situ of the breast
- 1 April 2002
- journal article
- research article
- Published by Springer Nature in Breast Cancer
- Vol. 9 (2) , 118-126
- https://doi.org/10.1007/bf02967576
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Immunohistochemical Expression of uPA, uPAR, and PAI-1 in Breast CarcinomaThe American Journal of Pathology, 2000
- Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trialThe Lancet, 1999
- Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-upBritish Journal of Cancer, 1999
- Cathepsin-D, urokinase plasminogen activator and type-1 plasminogen activator inhibitor in early breast cancer: an immunohistochemical study of prognostic value and relations to tenascin-C and other factorsBritish Journal of Cancer, 1999
- Cathepsin D in cancer metastasis: A protease and a ligandAPMIS, 1999
- Detection of Apoptotic Cells in Human Colorectal Cancer by Two Different in situ Methods: Antibody against Single‐stranded DNA and Terminal Deoxynucleotidyl Transferase‐mediated dUTP‐biotin Nick End‐labeling (TUNEL) MethodsJapanese Journal of Cancer Research, 1999
- Monoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of ApoptosisExperimental Cell Research, 1996
- Prognostic classification of breast ductal carcinoma-in-situThe Lancet, 1995
- Extent, distribution, and mammographic/ histological correlations of breast ductal carcinoma in situThe Lancet, 1990
- Ductal Carcinoma in Situ (Intraductal Carcinoma) of the BreastNew England Journal of Medicine, 1988